Jonathan S Zager

52PUBLICATIONS
104CO-AUTHORS
Tumour immunologyPredictive and prognostic markersLiquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jan 14, 2026
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial.

Andrew S Brohl, Vernon K Sondak, Evan J Wuthrick

|Jan 10, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Juan Alban, R Christopher Bowen, David A Reichstein

|May 24, 2025
Isolated Limb Infusion/Perfusion for Unresectable Acral Versus Non-Acral Melanoma In-Transit Metastases.

Michelle M Dugan, Jacob Israeli, Nicholas Chin

|May 10, 2025
Isolated Limb Infusion or Perfusion as First-Line Versus Second-Line Therapy for In-Transit Metastatic Melanoma.

Michelle M Dugan, Aleena Boby, Helana Ghali

|Apr 25, 2025
The Use of Radar-Guided Localization to Identify Metastatic Melanoma After Neoadjuvant Immunotherapy.

Michelle M Dugan, Kate E Beekman, Danielle K DePalo

Pageof 9